Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Total Debt (2016 - 2025)

Bio-Techne has reported Total Debt over the past 12 years, most recently at $260.0 million for Q4 2025.

  • For Q4 2025, Total Debt fell 13.33% year-over-year to $260.0 million; the TTM value through Dec 2025 reached $260.0 million, down 13.33%, while the annual FY2025 figure was $346.0 million, 8.46% up from the prior year.
  • Total Debt for Q4 2025 was $260.0 million at Bio-Techne, down from $300.0 million in the prior quarter.
  • Over five years, Total Debt peaked at $447.0 million in Q4 2023 and troughed at $200.0 million in Q4 2022.
  • A 5-year average of $314.0 million and a median of $300.1 million in 2021 define the central range for Total Debt.
  • Biggest five-year swings in Total Debt: plummeted 47.9% in 2021 and later surged 123.5% in 2023.
  • Year by year, Total Debt stood at $282.1 million in 2021, then dropped by 29.11% to $200.0 million in 2022, then skyrocketed by 123.5% to $447.0 million in 2023, then plummeted by 32.89% to $300.0 million in 2024, then decreased by 13.33% to $260.0 million in 2025.
  • Business Quant data shows Total Debt for TECH at $260.0 million in Q4 2025, $300.0 million in Q3 2025, and $346.0 million in Q2 2025.